Slovenia has observed a 30.72 million (8.6%) increase in the research & development by business enterprise, pharmaceutical industry in constant ppp $, which now stands at 388.80 million.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Slovenia
No matching regions
Download image
Business R&D pharmaceutical in constant PPP $ (millions), 2021
Full screenBusiness R&D pharmaceutical in constant PPP $ (millions), 2021
Close
Data currently not available for this time and region, try a different time period
Slovenia Business R&D pharmaceutical in constant PPP $ between 1993 and 2021
| Date | Slovenia |
|---|---|
| 2021 | 388.80 million |
| 2020 | 358.07 million |
| 2019 | 327.86 million |
| 2018 | 327.21 million |
| 2017 | 292.17 million |
| 2016 | 299.48 million |
| 2015 | 307.96 million |
| 2014 | 276.26 million |
| 2013 | 274.62 million |
| 2012 | 284.75 million |
| 2011 | 285.94 million |
| 2010 | 281.65 million |
| 2009 | 234.96 million |
| 2008 | 248.60 million |
| 2007 | 208.36 million |
| 2006 | 205.48 million |
| 2005 | 151.59 million |
| 2004 | 212.80 million |
| 2003 | 170.50 million |
| 2002 | 139.24 million |
| 2001 | 120.57 million |
| 2000 | 96.64 million |
| 1999 | 85.15 million |
| 1998 | 75.55 million |
| 1997 | 69.52 million |
| 1996 | 63.84 million |
| 1995 | 50.70 million |
| 1994 | 50.62 million |
| 1993 | 46.76 million |
Similar regions to Slovenia
Business R&D pharmaceutical in constant PPP $
More indicators for Slovenia
Government R&D in security as % of government support
0.52%
+0.01%
(2021)
Higher-education-finacing R&D financed by general university in local currency
132.61M
+34.71M
(2021)
R&D financed by rest of the world in local currency
2,937.64M
+456.30M
(2021)
Government R&D financed by rest of the world in local currency
231.81M
+23.05M
(2021)
Business R&D financed by rest of the world in local currency
2,450.24M
+401.21M
(2021)
Non-profit R&D growth rate
21.48%
-5.75%
(2022)
Slovenia Business R&D pharmaceutical in constant PPP $ between 1993 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 388.80M | +30.72M |
| 2020 | 358.07M | +30.21M |
| 2019 | 327.86M | +0.66M |
| 2018 | 327.21M | +35.04M |
| 2017 | 292.17M | -7.31M |
| 2016 | 299.48M | -8.48M |
| 2015 | 307.96M | +31.70M |
| 2014 | 276.26M | +1.64M |
| 2013 | 274.62M | -10.13M |
| 2012 | 284.75M | -1.19M |
| 2011 | 285.94M | +4.29M |
| 2010 | 281.65M | +46.69M |
| 2009 | 234.96M | -13.64M |
| 2008 | 248.60M | +40.24M |
| 2007 | 208.36M | +2.88M |
| 2006 | 205.48M | +53.88M |
| 2005 | 151.59M | -61.21M |
| 2004 | 212.80M | +42.30M |
| 2003 | 170.50M | +31.26M |
| 2002 | 139.24M | +18.67M |
| 2001 | 120.57M | +23.93M |
| 2000 | 96.64M | +11.50M |
| 1999 | 85.15M | +9.60M |
| 1998 | 75.55M | +6.03M |
| 1997 | 69.52M | +5.68M |
| 1996 | 63.84M | +13.14M |
| 1995 | 50.70M | +0.08M |
| 1994 | 50.62M | +3.86M |
| 1993 | 46.76M |